# Exploring Asthma Exacerbations in Mepolizumab Treated Patients

> **NCT03324230** · — · COMPLETED · sponsor: **Queen's University, Belfast** · enrollment: 146 (actual)

## Conditions studied

- Asthma Brittle

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03324230
- **Lead sponsor:** Queen's University, Belfast
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2019-06-29
- **Final completion:** 2019-06-29
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2019-07-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03324230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03324230, "Exploring Asthma Exacerbations in Mepolizumab Treated Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03324230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*